BPC-157 + TB-500 Blend
PreclinicalThe 'wolverine stack' — two repair mechanisms in one vial, a decade of folklore and zero controlled trials.
What it is
This blend combines BPC-157 with a component sold as TB-500, commonly around 10mg of each. BPC-157 is the 15-amino-acid gastric-juice-derived repair peptide; TB-500 labeling is inconsistent, sometimes meaning the short fragment, sometimes borrowing from the full thymosin beta-4 literature. Neither has an FDA-approved healing indication.
How it works
The pair splits the repair job across two pathways. BPC-157 is framed around blood-vessel growth, nitric oxide signaling, and local tissue models. The TB-500 side leans on actin regulation and cell migration from the thymosin beta-4 biology. A plausible stack — but plausibility is not proof.
What people report
- ✦Rotator cuff, achilles, and tendon-strain recovery is the dominant use
- ✦Lateral epicondylitis, plantar fasciitis, and MCL strains come up often
- ✦Post-procedure recovery narratives
- ✦The most coherent healing blend on the market, by mechanism
Typical use
Typically injected daily or every few days for a multi-week recovery block.
Dosing reference
Usually a few hundred micrograms to low milligrams of each per dose. No approved dose.
Reference only — not a recommendation. Verify via primary sources.
Watch for
The preclinical case for the components is real, but no controlled study shows the combination accelerates human tendon or surgical recovery. Structural injuries, full tears, and advanced arthritis sit outside peptide mythology.
Notes
Earns attention because the mechanisms line up and the reports persist. It does not earn certainty.
Educational content — not medical advice.